Senta Müller1, Ute Laber, Jost Müllenheim
1Institut für Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universität, Moorenstrasse 5, 40225 Duesseldorf, Germany.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Long-term, eccentric isosorbide mononitrate (ISMN) treatment did not increase vascular superoxide production or impair endothelial function, even with moderate nitrate tolerance. This suggests ISMN is unlikely to worsen endothelial dysfunction in coronary artery disease.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: